Tong Ren Tang Technologies Obtains Hong Kong Certificate for Sanzi Yangqin Keli, Extending Product Line to 2031

Bulletin Express

Aug 28

Tong Ren Tang Technologies Co. Ltd. (Tong Ren Tang) announced that its wholly-owned subsidiary, Beijing Tong Ren Tang Chinese Medicine Company Limited, has secured the Certificate of Registration of Proprietary Chinese Medicine from the Chinese Medicine Council of Hong Kong. The approval authorises the sale of “Sanzi Yangqin Keli【Tong Ren Tang】” in the Hong Kong Special Administrative Region.

Key details • Product: Sanzi Yangqin Keli【Tong Ren Tang】 • Registration number: HKC-18820 • Certificate validity: through 25 August 2031 • Cumulative R&D investment: approximately HK$0.80 million (unaudited) • Commercial status: product yet to be launched

Strategic implications The new certification enables immediate market entry in Hong Kong, broadening the Group’s proprietary Chinese medicine portfolio. Management expects the licence to support future market expansion; however, it does not anticipate a material near-term impact on production, operations or financial performance. The company highlights potential risks from regulatory changes, currency fluctuations and competitive pressures in the Hong Kong market.

Shareholders and prospective investors are advised to remain prudent when dealing in Tong Ren Tang securities.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/news/1165610867"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1165610867\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1165610867?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-28 19:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1165610867","market":"us","top_or_hot":-1,"title":"Tong Ren Tang Technologies Obtains Hong Kong Certificate for Sanzi Yangqin Keli, Extending Product Line to 2031","media":"Bulletin Express","content":" \n<p>Tong Ren Tang Technologies Co. Ltd. (Tong Ren Tang) announced that its wholly-owned subsidiary, Beijing Tong Ren Tang Chinese Medicine Company Limited, has secured the Certificate of Registration of Proprietary Chinese Medicine from the Chinese Medicine Council of Hong Kong. The approval authorises the sale of “Sanzi Yangqin Keli【Tong Ren Tang】” in the Hong Kong Special Administrative Region.</p>\n<p>Key details  \n• Product: Sanzi Yangqin Keli【Tong Ren Tang】  \n• Registration number: HKC-18820  \n• Certificate validity: through 25 August 2031  \n• Cumulative R&D investment: approximately HK$0.80 million (unaudited)  \n• Commercial status: product yet to be launched</p>\n<p>Strategic implications  \nThe new certification enables immediate market entry in Hong Kong, broadening the Group’s proprietary Chinese medicine portfolio. Management expects the licence to support future market expansion; however, it does not anticipate a material near-term impact on production, operations or financial performance. The company highlights potential risks from regulatory changes, currency fluctuations and competitive pressures in the Hong Kong market.</p>\n<p>Shareholders and prospective investors are advised to remain prudent when dealing in Tong Ren Tang securities.</p>\n","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tong Ren Tang Technologies Obtains Hong Kong Certificate for Sanzi Yangqin Keli, Extending Product Line to 2031</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTong Ren Tang Technologies Obtains Hong Kong Certificate for Sanzi Yangqin Keli, Extending Product Line to 2031\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-28 19:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n \n<p>Tong Ren Tang Technologies Co. Ltd. (Tong Ren Tang) announced that its wholly-owned subsidiary, Beijing Tong Ren Tang Chinese Medicine Company Limited, has secured the Certificate of Registration of Proprietary Chinese Medicine from the Chinese Medicine Council of Hong Kong. The approval authorises the sale of “Sanzi Yangqin Keli【Tong Ren Tang】” in the Hong Kong Special Administrative Region.</p>\n<p>Key details  \n• Product: Sanzi Yangqin Keli【Tong Ren Tang】  \n• Registration number: HKC-18820  \n• Certificate validity: through 25 August 2031  \n• Cumulative R&D investment: approximately HK$0.80 million (unaudited)  \n• Commercial status: product yet to be launched</p>\n<p>Strategic implications  \nThe new certification enables immediate market entry in Hong Kong, broadening the Group’s proprietary Chinese medicine portfolio. Management expects the licence to support future market expansion; however, it does not anticipate a material near-term impact on production, operations or financial performance. The company highlights potential risks from regulatory changes, currency fluctuations and competitive pressures in the Hong Kong market.</p>\n<p>Shareholders and prospective investors are advised to remain prudent when dealing in Tong Ren Tang securities.</p>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01666","symbol_name":"同仁堂科技","start_time":0,"source_url":"","article_id":"1165610867","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1165610867","pubTimestamp":1787916257,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Tong Ren Tang Technologies Co. Ltd. (Tong Ren Tang) announced that its wholly-owned subsidiary, Beijing Tong Ren Tang Chinese Medicine Company Limited, has secured the Certificate of Registration of...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01666":"同仁堂科技"},"translate_title":"同仁堂科技三子养琴可力获香港认证，产品线延伸至2031年","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01666":1},"content_text":"Tong Ren Tang Technologies Co. Ltd. (Tong Ren Tang) announced that its wholly-owned subsidiary, Beijing Tong Ren Tang Chinese Medicine Company Limited, has secured the Certificate of Registration of Proprietary Chinese Medicine from the Chinese Medicine Council of Hong Kong. The approval authorises the sale of “Sanzi Yangqin Keli【Tong Ren Tang】” in the Hong Kong Special Administrative Region.\nKey details  \n• Product: Sanzi Yangqin Keli【Tong Ren Tang】  \n• Registration number: HKC-18820  \n• Certificate validity: through 25 August 2031  \n• Cumulative R&D investment: approximately HK$0.80 million (unaudited)  \n• Commercial status: product yet to be launched\nStrategic implications  \nThe new certification enables immediate market entry in Hong Kong, broadening the Group’s proprietary Chinese medicine portfolio. Management expects the licence to support future market expansion; however, it does not anticipate a material near-term impact on production, operations or financial performance. The company highlights potential risks from regulatory changes, currency fluctuations and competitive pressures in the Hong Kong market.\nShareholders and prospective investors are advised to remain prudent when dealing in Tong Ren Tang securities.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}